Mankind Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Mankind Pharma has a total shareholder equity of ₹107.9B and total debt of ₹4.7B, which brings its debt-to-equity ratio to 4.4%. Its total assets and total liabilities are ₹139.8B and ₹31.9B respectively. Mankind Pharma's EBIT is ₹23.2B making its interest coverage ratio -275.7. It has cash and short-term investments of ₹47.3B.
Key information
4.4%
Debt to equity ratio
₹4.72b
Debt
| Interest coverage ratio | -275.7x |
| Cash | ₹47.27b |
| Equity | ₹107.89b |
| Total liabilities | ₹31.93b |
| Total assets | ₹139.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543904's short term assets (₹85.4B) exceed its short term liabilities (₹28.9B).
Long Term Liabilities: 543904's short term assets (₹85.4B) exceed its long term liabilities (₹3.0B).
Debt to Equity History and Analysis
Debt Level: 543904 has more cash than its total debt.
Reducing Debt: 543904's debt to equity ratio has reduced from 6.1% to 4.4% over the past 5 years.
Debt Coverage: 543904's debt is well covered by operating cash flow (492.2%).
Interest Coverage: 543904 earns more interest than it pays, so coverage of interest payments is not a concern.